Nearly half of US adults who drink and use cannabis combine them at once; cannabis use disorder drives the trend, signaling urgent screening needs.
|Slideshows|November 4, 2015
Deconstructing ADHD, Addiction, and Beyond
Author(s)Anthony M. Ocana, MD, MSc
Listen
0:00 / 0:00
News and research highlights on ADHD, conduct disorder, substance use disorder, and behavioral addictions, including compulsive social networking.
Advertisement
 Dr Anthony Ocana summarizes the latest news and research highlights on ADHD. Scroll through the slides for sources. To view in PDF format, click here.
Advertisement
Related to this article
FDA grants Breakthrough Device status to NET Recovery’s tACS wearable, aiming to curb cocaine and meth use and close a major treatment gap.
Early trial shows investigational orexin-2 agonist ALKS 7290 improves adult ADHD symptoms in 14 days, with tolerable safety, paving way for phase 2.
Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psychiatric Pipeline in Review: Quarter 3, 2026
2
VA Expands Informed Consent Requirements for Psychotropic Medications Starting in 2027
3
Psychedelics as a Catalyst for Change: The Evolving Competitive Landscape in Depression
4
September 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
5